Cargando…
Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research
INTRODUCTION: Hypertension patients often suffered from insomnia problems which lowered the quality of life. Studies have shown that acupuncture is effective to treat perimenopausal and cancer-related insomnia. However, there is a lack of randomized controlled trials to support the effectiveness of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757932/ https://www.ncbi.nlm.nih.gov/pubmed/35029187 http://dx.doi.org/10.1097/MD.0000000000028455 |
_version_ | 1784632790344531968 |
---|---|
author | Zhu, Xun Yan, Luda Dou, Xuejiao Zheng, Yanping He, Guanglin Liao, Meiyan Fu, Wenbin |
author_facet | Zhu, Xun Yan, Luda Dou, Xuejiao Zheng, Yanping He, Guanglin Liao, Meiyan Fu, Wenbin |
author_sort | Zhu, Xun |
collection | PubMed |
description | INTRODUCTION: Hypertension patients often suffered from insomnia problems which lowered the quality of life. Studies have shown that acupuncture is effective to treat perimenopausal and cancer-related insomnia. However, there is a lack of randomized controlled trials to support the effectiveness of acupuncture on insomnia of hypertension patients. METHODS AND ANALYSIS: This study is a randomized, double-blind (patients and evaluators), and placebo-controlled clinical trial to investigate the effect of acupuncture in hypertension patients’ insomnia management. We will recruit 158 hypertension patients suffering from insomnia in Bao’an People's Hospital, Shenzhen and randomly assign them into treatment group (antihypertensive drugs + acupuncture) and control group (antihypertensive drugs + sham acupuncture) in a 1:1 ratio. The patients will receive acupuncture 3 times a week for 12 weeks, and then a 6-months follow-up will be conducted after the treatment. The primary outcome is the Pittsburgh Sleep Quality Index. The secondary outcomes include sleep parameters, blood pressure dropping, sleeping pill dosage, Rating Depression Scale score, and Self-Rating Anxiety Scale score. The primary outcome will be evaluated at baseline, 4, 8, and 12 weeks, and 1, 3, and 6 months following the end of treatment. The secondary outcomes will be assessed at baseline and 12 weeks of the treatment period. |
format | Online Article Text |
id | pubmed-8757932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-87579322022-01-19 Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research Zhu, Xun Yan, Luda Dou, Xuejiao Zheng, Yanping He, Guanglin Liao, Meiyan Fu, Wenbin Medicine (Baltimore) 3400 INTRODUCTION: Hypertension patients often suffered from insomnia problems which lowered the quality of life. Studies have shown that acupuncture is effective to treat perimenopausal and cancer-related insomnia. However, there is a lack of randomized controlled trials to support the effectiveness of acupuncture on insomnia of hypertension patients. METHODS AND ANALYSIS: This study is a randomized, double-blind (patients and evaluators), and placebo-controlled clinical trial to investigate the effect of acupuncture in hypertension patients’ insomnia management. We will recruit 158 hypertension patients suffering from insomnia in Bao’an People's Hospital, Shenzhen and randomly assign them into treatment group (antihypertensive drugs + acupuncture) and control group (antihypertensive drugs + sham acupuncture) in a 1:1 ratio. The patients will receive acupuncture 3 times a week for 12 weeks, and then a 6-months follow-up will be conducted after the treatment. The primary outcome is the Pittsburgh Sleep Quality Index. The secondary outcomes include sleep parameters, blood pressure dropping, sleeping pill dosage, Rating Depression Scale score, and Self-Rating Anxiety Scale score. The primary outcome will be evaluated at baseline, 4, 8, and 12 weeks, and 1, 3, and 6 months following the end of treatment. The secondary outcomes will be assessed at baseline and 12 weeks of the treatment period. Lippincott Williams & Wilkins 2022-01-14 /pmc/articles/PMC8757932/ /pubmed/35029187 http://dx.doi.org/10.1097/MD.0000000000028455 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 3400 Zhu, Xun Yan, Luda Dou, Xuejiao Zheng, Yanping He, Guanglin Liao, Meiyan Fu, Wenbin Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research |
title | Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research |
title_full | Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research |
title_fullStr | Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research |
title_full_unstemmed | Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research |
title_short | Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research |
title_sort | acupuncture treatment of hypertension with insomnia: a protocol for randomized, double-blind, placebo controlled trial research |
topic | 3400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757932/ https://www.ncbi.nlm.nih.gov/pubmed/35029187 http://dx.doi.org/10.1097/MD.0000000000028455 |
work_keys_str_mv | AT zhuxun acupuncturetreatmentofhypertensionwithinsomniaaprotocolforrandomizeddoubleblindplacebocontrolledtrialresearch AT yanluda acupuncturetreatmentofhypertensionwithinsomniaaprotocolforrandomizeddoubleblindplacebocontrolledtrialresearch AT douxuejiao acupuncturetreatmentofhypertensionwithinsomniaaprotocolforrandomizeddoubleblindplacebocontrolledtrialresearch AT zhengyanping acupuncturetreatmentofhypertensionwithinsomniaaprotocolforrandomizeddoubleblindplacebocontrolledtrialresearch AT heguanglin acupuncturetreatmentofhypertensionwithinsomniaaprotocolforrandomizeddoubleblindplacebocontrolledtrialresearch AT liaomeiyan acupuncturetreatmentofhypertensionwithinsomniaaprotocolforrandomizeddoubleblindplacebocontrolledtrialresearch AT fuwenbin acupuncturetreatmentofhypertensionwithinsomniaaprotocolforrandomizeddoubleblindplacebocontrolledtrialresearch |